Endogena finalises enrolment for retinitis pigmentosa trial
PharmaTimes
MAY 4, 2023
The treatment is a small molecule that activates endogenous retinal stem and progenitor cells
Sat.Apr 29, 2023 - Fri.May 05, 2023
104 
ChatGPT Outperforms Doctors In Answering Patient Messages, Study Shows
MedCity News
APRIL 30, 2023
A new study found that ChatGPT might actually be quite successful in providing high-quality answers to patient questions during an era in which doctors and nurses are too busy to do so. The research evaluated two sets of answers to patient inquiries — one written by physicians, the other by ChatGPT. A panel of healthcare professionals determined that ChatGPT’s answers were significantly more detailed and empathetic.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
A CEO’s quest to solve a 400-year-old medical mystery — and he’s also a patient
PharmaVoice
MAY 1, 2023
The CEO of Ventoux Biosciences has the disease that his company is aiming to treat, and it's driving him to find better medications.
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win
Fierce Pharma
MAY 3, 2023
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win aliu Wed, 05/03/2023 - 14:50
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharma’s social media problem
Dominic Tyer
MAY 5, 2023
Pharma has an opportunity to make more effective - and wider - use of social media, but companies are not currently meeting HCP expectations
Telehealth Companies Applaud DEA for Delaying Telemedicine Restrictions of Controlled Substances
MedCity News
MAY 3, 2023
The Drug Enforcement Administration received 38,000 comments on its proposed rule that would roll back Covid-19 flexibilities for the prescribing of controlled substances via telemedicine. In response, the DEA chose to temporarily extend the flexibilities, a decision telehealth companies like Bicycle Health and Mindbloom are in support of.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy
Fierce Pharma
MAY 1, 2023
Teva, MedinCell win FDA approval for slow-release schizophrenia drug Uzedy kdunleavy Mon, 05/01/2023 - 07:35
Mobile Printer Produces Microneedle Vaccines
Medgadget
MAY 3, 2023
Researchers at MIT have developed a printer that can create large numbers of microneedle patch-style vaccines in places where they are needed quickly. Moreover, the printed patches can deliver thermostable mRNA vaccines, whereby the mRNA therapeutic is encapsulated in lipid nanoparticles before printing to enhance its shelf-life at room temperature and avoid the need for cold storage and transport.
Virtual Primary Care: The New Frontier of Healthcare Delivery [Sponsored]
MedCity News
MAY 3, 2023
In an interview, Rob Bressler, general manager for Teladoc Health’s virtual primary care solution Primary360, talked about the company’s shift from telehealth for urgent care to whole person care.
Astellas Pharma agrees to buy Iveric bio for about $5.9bn
Pharmaceutical Technology
MAY 1, 2023
Astellas Pharma has entered into a definitive agreement to buy US-based biopharmaceutical company Iveric bio, in a deal valued at nearly $5.9bn. Under the deal terms, the company, through Astellas US Holding’s wholly owned subsidiary Berry Merger Sub, will acquire all the outstanding Iveric Bio shares for $40.00 in cash for each share. Both the companies’ Boards of Directors have unanimously approved the deal.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim
Fierce Pharma
MAY 2, 2023
Merck entitled to $1.
Graphene Patch Affixes to Heart for Pacemaking
Medgadget
MAY 1, 2023
Researchers at Northwestern University and the University of Texas at Austin have developed a thin and flexible graphene “tattoo” that can be affixed to the outside of the heart, and which can monitor heart rhythms and apply corrective electrical impulses to treat arrhythmias. The patch is optically clear, allowing the researchers to also use light to monitor and stimulate the heart.
VC Identifies 3 Startups That Will Shake Up the Future of Cancer Care
MedCity News
MAY 4, 2023
Oncology Ventures recently announced investments in three cancer startups — VivorCare, Gabbi and Health Universe. The fund’s founding partner said each company demonstrated an ability to tackle a specific problem within the cancer care space, such as enabling earlier breast cancer diagnoses and providing personalized care plans for cancer survivors.
FDA revokes EUAs of Pfizer/BioNTech’s and Moderna’s original Covid-19 vaccines
Pharmaceutical Technology
MAY 2, 2023
The FDA recently announced the expansion of the emergency use authorizations (EUAs) of both Pfizer/BioNTech’s and Moderna’s bivalent original/Omicron BA.4/5 Covid-19 messenger RNA (mRNA) vaccines. The expanded EUAs state that these current bivalent vaccines are now to be used for all primary and booster doses administered to individuals ages six months of age and older.
Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets
Fierce Pharma
MAY 2, 2023
Pfizer pulls off Q1 surprise with strong sales even as COVID vaccine demand plummets kdunleavy Tue, 05/02/2023 - 09:27
Why R&D innovation holds the key to greater patient impact
European Pharmaceutical Review
MAY 2, 2023
Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 1,2 In the EU, an estimated 2.7 million people are diagnosed with cancer annually and the number is growing. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients.
Formus Labs’ Hip Surgery Planning Software Expands into the US with FDA Clearance
MedCity News
MAY 5, 2023
Formus Labs, a New Zealand-based medical technology startup, has received 510(k) clearance from the FDA for Formus Hip, its fully automated 3D software for hip replacement preoperative planning. The company hopes to start piloting the product at healthcare sites across the U.S. in the next few months.
Taking your biotech global? Here’s how you can navigate cultural norms
PharmaVoice
MAY 2, 2023
What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
GSK staffers kick off series of strikes in UK for the first time in drugmaker's history
Fierce Pharma
MAY 2, 2023
GSK staffers kick off series of strikes in UK for the first time in drugmaker's history aliu Tue, 05/02/2023 - 14:22
Digital transformation to drive biomanufacturing market
European Pharmaceutical Review
MAY 3, 2023
A market report has shown that the digital biomanufacturing market is anticipated to grow at a compound annual growth rate (CAGR) of 11 percent between 2023-2035, driven largely by digital transformation. Influencing factors identified in the report include higher competition, competitive pricing and inflation rate, technological advancements and evolving regulatory guidelines.
As Workforce Shortages Intensify, CMS’ Value-based Care Ambitions Hang in the Balance
MedCity News
MAY 5, 2023
Absent the ability to bolster their ranks with more clinicians, what rural health centers need first and foremost to shift to value are technologies that amplify their clinical capacity without further burdening and burning out their core staff.
Emalex aims at a first-in-class breakthrough for Tourette syndrome
PharmaVoice
MAY 1, 2023
With its phase 3 candidate, the biotech believes it can move the field beyond antipsychotics to a more effective approach.
How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
J&J's consumer group Kenvue set for $41B IPO, the largest US market debut in more than a year
Fierce Pharma
MAY 4, 2023
J&J's consumer group Kenvue set for $41B IPO, the largest US market debut in more than a year esagonowsky Thu, 05/04/2023 - 09:58
Forge Biologics and Labcorp partner for gene therapies development
Pharmaceutical Technology
MAY 4, 2023
Forge Biologics and global life sciences company Labcorp have announced a strategic adeno-associated virus (AAV) gene therapy development and manufacturing collaboration. Gene therapy clients will gain access to coordinated scientific expertise, drug development services and AAV manufacturing capabilities, advancing the development of new gene therapies.
Report: Noncitizens Will Account for One-third of Uninsured Population in 2024
MedCity News
MAY 4, 2023
A recent Urban Institute report found that the uninsurance rate for nonelderly people who aren’t citizens will be 39.2% in 2024, about four times higher than it is for the entire U.S. population at 9.8%.
Wound Dressing Detects Infection, Changes Color
Medgadget
MAY 1, 2023
Researchers at Linköping University in Sweden created a wound dressing that can provide a visual indication if the underlying wound is infected. Chronic wounds are difficult to manage, and presently healthcare staff must remove the dressing regularly to check if an infection is developing. However, this can disrupt the wound by damaging the scab, impairing healing, and may even introduce pathogens in the process.
How to Stay Competitive in the Evolving State of Martech
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Struggling Biogen paid its 2 CEOs more than $57M last year, including $30.5M to new chief Chris Viehbacher
Fierce Pharma
MAY 1, 2023
Struggling Biogen paid its 2 CEOs more than $57M last year, including $30.
Kry showcases digital care pathways
PharmaTimes
MAY 5, 2023
Systems will support millions of patients with chronic respiratory conditions throughout Europe
Mount Sinai Doctors Vote to Strike Over Pay, Benefits Disparities
MedCity News
MAY 4, 2023
Resident physicians at Mount Sinai’s Elmhurst Hospital in Queens have voted to authorize a strike. The union that represents these residents has noticed significant disparities in Mount Sinai’s compensation and benefits when compared to the resident physicians employed at the health system’s flagship hospital in Manhattan.
MIT unlocks real-time powder particle size distribution monitoring
European Pharmaceutical Review
MAY 5, 2023
Researchers have developed a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can extract the particle size distribution (PSD) of a pharmaceutical powder surface from its laser speckle. The method provides a real-time, non-invasive, far-field optical probe to monitor particle size distributions quantitatively.
Let's personalize your content